AbCellera Appoints Dr. Lynn Seely to its Board of Directors
AbCellera appointed Dr. Lynn Seely, M.D., to its Board of Directors as an independent director, effective immediately. Dr. Seely brings extensive experience as the current CEO of Lyell Immunopharma and previously Myovant Sciences, where she commercialized therapies for women’s health.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.